Penobscot Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Penobscot Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,153	Closed	-$241K	–	249
2021 Q4	$241K	Sell	2,153 -1,337	-38%	-$161K	0.03%	228
2021 Q3	$439K	Buy	3,490 +90	+3%	+$11.6K	0.07%	173
2021 Q2	$460K	Buy	3,400 +730	+27%	+$96K	0.07%	166
2021 Q1	$362K	Buy	2,670 +990	+59%	+$148K	0.06%	177
2020 Q4	$237K	Buy	+1,680	New	+$215K	0.04%	197

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Penobscot Investment Management's XBI Position: Q1 2022 in Review

Penobscot Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 2,153 shares — an estimated $241K sold.

Penobscot Investment Management first reported a position in XBI in Q4 2020 and held it in 5 quarters. The position peaked at $460K in Q2 2021. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Penobscot Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Penobscot Investment Management sold 2,153 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $241K.
Penobscot Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 5 quarters.
Penobscot Investment Management's State Street SPDR S&P Biotech ETF position peaked at $460K in Q2 2021.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Penobscot Investment Management's 13F filing for Q1 2022, filed 11 May 2022.